Feed/Investors/HBM Genomics

HBM Genomics

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2020-07-22

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$135M

across 1 round

LATEST ROUND

Series D+ · $135M · 2020-07-22

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

HBM Genomics: 1 round · Fireround

Company	Round	Amount	Announced	Role
Encoded Therapeutics Encoded Therapeutics develops gene therapies targeting genetic disorders, primarily focusing on neurological conditions.	Series D+ Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$135M	2020-07-22	[ PART ]